Sunitinib inducing tumor lysis syndrome in a patient treated for renal carcinoma

By Michels Judith   Lassau Nathalie   Gross-Goupil Marine   Massard Christophe   Mejean Arnaud   Escudier Bernard  

Investigational New Drugs, Vol. 28, Iss. 5, 2010-10 ,pp. : 690-693

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of 2-methoxyestradiol nanocrystal colloidal dispersion alone and in combination with sunitinib malate in patients with metastatic renal cell carcinoma progressing on sunitinib malate

By Bruce Justine  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 794-802

Springer Publishing Company

Access to resources Recommend Favorite

Reflex sympathetic dystrophy in patients with metastatic renal cell carcinoma treated with Everolimus

By Massard Christophe   Fizazi Karim   Gross-Goupil Marine   Escudier Bernard  

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 879-881

Springer Publishing Company

Access to resources Recommend Favorite

Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma

By  

Cancer, Vol. 121, Iss. 19, 2015-10 ,pp. : 3435-3443

Blackwell Publishing

Access to resources Recommend Favorite

Response to Sorafenib in a Patient with Metastatic Xp11 Translocation Renal Cell Carcinoma

By Hou Ming-Mo  

Clinical Drug Investigation, Vol. 30, Iss. 11, 2010-11 ,pp. : 799-804

Adis International

Access to resources Recommend Favorite